The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...

Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...

Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...

The U.S. Food and Drug Administration (FDA) has granted Biogen’s investigational drug, litifilimab, Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus (CLE).

Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest. Discover and match to lupus clinical trials faster with our ...

A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic ...

The physical, emotional and financial toll of lupus can be invisible to those who don’t live with this disease. Lupus symptoms affect each person differently, and it can be difficult for those without ...